Global PGM Sequencer Market Growth 2023-2029

Global PGM Sequencer Market Growth 2023-2029

The global PGM Sequencer market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for PGM Sequencer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for PGM Sequencer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for PGM Sequencer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key PGM Sequencer players cover Thermo Fisher Scientific, Illumina, Roche Diagnostics, BGI Genomics Co.,Ltd., Oxford Nanopore Technologies, Shimadzu and Fapon Biotech Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “PGM Sequencer Industry Forecast” looks at past sales and reviews total world PGM Sequencer sales in 2022, providing a comprehensive analysis by region and market sector of projected PGM Sequencer sales for 2023 through 2029. With PGM Sequencer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PGM Sequencer industry.

This Insight Report provides a comprehensive analysis of the global PGM Sequencer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PGM Sequencer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global PGM Sequencer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PGM Sequencer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PGM Sequencer.

This report presents a comprehensive overview, market shares, and growth opportunities of PGM Sequencer market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Small Flux
Medium Flux
Large Throughput

Segmentation by application
Genomics Research
Exome Sequencing
Targeted Sequencing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
Roche Diagnostics
BGI Genomics Co.,Ltd.
Oxford Nanopore Technologies
Shimadzu
Fapon Biotech Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global PGM Sequencer market?

What factors are driving PGM Sequencer market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do PGM Sequencer market opportunities vary by end market size?

How does PGM Sequencer break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.